Ultrastructural and phenotypic characterization of CABA I, a new human ovarian cancer cell line

Oncology Research

Volumn 9, Issue 3, 1997, Pages 129-138

  Dolo, Vincenza ^a   Ginestra, Angela ^a  

^a UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

C erbb 2; CABA I; Cell line; Ovarian carcinoma

Indexed keywords

TUMOR ANTIGEN;

ANIMAL; ARTICLE; ASCITES; CANCER TRANSPLANTATION; CARCINOMA; CELL CULTURE; CHROMOSOME BANDING PATTERN; ELECTRON MICROSCOPY; FEMALE; FLOW CYTOMETRY; HUMAN; MIDDLE AGED; MOUSE; OVARY TUMOR; PATHOLOGY;

ANIMALS; ANTIGENS, NEOPLASM; ASCITES; CARCINOMA; CHROMOSOME BANDING; FEMALE; FLOW CYTOMETRY; HUMANS; MICE; MICROSCOPY, ELECTRON; MIDDLE AGED; NEOPLASM TRANSPLANTATION; OVARIAN NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0030629028     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Piver, M. S.; Baker, T. R.; Piedmonte, M.; Sandeki, A. M. Epidemiology and etiology of ovarian cancer. Semin. Oncol. 18:177-185; 1991.
2. Morrow, C.; Curtin, J. P.; Townsend, D. E. Synopsis of gynecologic oncology, 4th ed. New York: Wiley; 1993.
3. Provencher, D. M.; Finstad, C. L.; Saigo, P. E.; Rubin, S. C.; Hoskins, W. J.; Federici, M. G.; Stocken, E.; Lloyd, K. O.; Lewis, J. L., Jr. Comparison of antigen expression on fresh and cultured ascites cells and on solid tumors of patients with epithelial ovarian cancer. Gynecol. Oncol. 50:78-83; 1993.
4. Burg, C. J.; Van der Burg, M. E. L.; Foekens, J. A. Receptors for hormones and growth factors and (onco)-gene amplification in human ovarian cancer. Int. J. Cancer 52:218-224; 1992.
5. Brodsky, F. M.; Parham, P. Monomorphic anti-HLA-A, B, C monoclonal antibodies detecting molecular subunits and combinatorial determinants. J. Immunol. 128:129-135; 1982.
6. Menard, S.; Tagliabue, E.; Canevari, S.; Fossati, G.; Colnaghi, M. I. Generation of monoclonal antibodies reacting with normal and cancer cells of human breast. Cancer Res. 43:1295-1300; 1983.
7. Miotti, S.; Canevari, S.; Ménard, S.; Mezzanzanica, D.; Porro, G.; Pupa, S. M.; Regazzoni, M.; Tagliabue, E.; Colnaghi, M. I. Characterization of human ovarian carcinomaassociated antigens defined by novel monoclonal antibodies with tumor-restricted specificity. Int. J. Cancer 39:297-303; 1987.
8. Tosi, E.; Valota, O.; Negri, D. R. M.; Adobati, E.; Mazzoni, A.; Meazza, R.; Ferrini, S.; Colnaghi, M. I.; Canevari, S. Anti-tumor efficacy of an anti-epidermal-growth-factor-receptor monoclonal antibody and its F(ab')2 fragment against high- and low-EGFR-expressing carcinomas in nude mice. Int. J. Cancer 62:643-650; 1995.
9. Centis, F.; Tagliabue, E.; Uppugunduri, S.; Pellegrini, R.; Martignone, S.; Mastroianni, A.; Ménard, S.; Colnaghi, M. I. HER/neu epitope mapping with murine monoclonal antibodies. Hybridoma 11:267-276; 1992.
10. Leoni, F.; Colnaghi, M. I.; Canevari, S.; Ménard, S.; Colzani, E.; Facheris, P.; Figini, M.; Miotti, S.; Magnani, J. L. Glycolipids carrying Ley are preferentially expressed on small-cell lung cancer cells as detected by the monoclonal antibody MLuCl. Int. J. Cancer 51:225-231; 1992.
11. Martignone, S.; Ménard, S.; Bufalino, R.; Cascinelli, N.; Pellegrini, R.; Tagliabue, E.; Andreola, S.; Rilke, F.; Colnaghi, M. 1. Prognostic significance of the 67-kilodaIton laminin receptor expression in human breast carcinomas. J. Natl. Cancer Inst. 85:398-402; 1993.
12. Pellegrini, R.; Bazzini, P.; Tosi, E.; Tagliabue, E.; Conforti, G.; Dejana, E.; Ménard, S.; Colnaghi, M. I. Production and characterization of two monoclonal antibodies directed against the integrin/31 chain. Tumori 78:1-4; 1992.
13. Bottini, C.; Miotti, S.; Fiorucci, S.; Facheris, P.; Ménard, S.; Colnaghi, M. I. Polarization of the < 6/34 integrin in ovarian carcinomas. Int. J. Cancer 54:261-267; 1993.
14. Jones, J. C. R.; Kurpakus, M. A.; Cooper, H. M.; Quaranta, V. A function for the integrin a64 in the hemidesmosome. Cell Regul. 2:427-438; 1991.
15. Sheehan, K. C.; Calderon, J.; Schreiber, R. D. Generation and characterization of monoclonal antibodies specific for the human IFN-gamma receptor. J. Immunol. 140:4231-4237; 1988.
16. Smith, C.; Davis, T.; Wignall, J.; Din, W.; Farrah, T.; Upton, C.; McFadden, G.; Goodwin, R. G. T2 open reading frame from the Shope fibroma virus encodes a soluble form of the TNF receptor. Biochem. Biophys. Res. Commun. 176: 335-340; 1991.
17. Levy, R.; Czernobilsky, B.; Geiger, B. Subtyping of epithelial cells of normal and metaplastic human uterine cervix, using polypeptide-specific cytokeratin antibodies. Differentiation 39:185-196; 1988.
18. Southgate, J.; Williams, H. K.; Trejdosiewicz, L. K.; Hodges, G. M. Primary culture of human epithelial cells. Growth requirements and expression of differentiated characteristics. Lab. Invest. 56:211-223; 1987.
19. Kraus, J. H.; Issing, W.; Miki, T.; Popescu, N. C.; Aaronson, S. A. Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: Evidence for overexpression in a subset of human mammary tumors. Proc. Natl. Acad. Sei. USA 86:9193-9197; 1989.
20. erbB4, a fourth member of the epidermal growth factor receptor family. Proc. Natl. Acad. Sei. USA 90:1746-1750; 1993.
21. Reynolds, E. S. The use of lead citrate at high pH as an electron-opaque stain in electronmicroscopy. J. Cell Biol. 17: 208-212;1963.
22. Fuchtner, C.; Emma, D. A.; Manetta, A.; Gamboa, G.; Bernstein, R.; Liao, S. Y. Characterization of newly established human ovarian carcinoma cell line: UCI 101. Gynecol. Oncol. 48:203-209; 1993.
23. Hamburger, A. W.; Salmon, S. E.; Kim, M. B.; Trent, J. M.; Soehnlen, B. J.; Alberts, D. S.; Schmidt, H. J. Direct cloning of human ovarian carcinoma cells in agar. Cancer Res. 38: 3438-3444;1978.
24. Albanese, I.; Alberti, M.; Bazan, V.; Russo, A.; Baiamonte, S.; Migliavacca, M.; Bazan, P.; La Farina, M. Structural analysis of c-myc in human sporadic colorectal carcinomas. Anticancer Res. 14:1103-1106; 1994.
25. Hongyo, T.; Buzard, G. S.; Calvert, R. J.; Weghorst, C. M. Cold SSCP: A simple, rapid and non-radioactive method for optimized single-strand conformation polymorphism analyses. Nucleic Acids Res. 21(16):3637-3642; 1993.
26. Albanese, I.; Rinaudo, C. D.; AIberti, M.; Bazan, V.; Russo, A.; Migliavacca, M.; Bazan, P.; Dardanoni, G.; Tomasino, R. M.; La Farina, M. ras and myc analysis in primary and metastatic colorectal carcinomas -specific ras mutations are associated with Duke's D stage and mucinous histotype. Int. J.Oncol. 10:293-300; 1997.
27. Cripps, K. J.; Purdic, C. A.; Carder, P. J.; White, S.; Komine, K.; Bird, C. C.; Wyllie, A. M. A study of stabilization of p53 protein versus point mutation in colorectal carcinoma. Oncogene 9:2739-2743; 1994.
28. Miotti, S.; Facheris, P.; Tomassetti, A.; Bottero, F.; Bottini, C.; Ottone, F.; Colnaghi, M. 1.; Bunni, M. A.; Priest, D. G.; Canevari, S. Growth of ovarian-carcinoma cell lines at physiological folate concentration: Effect on folate-binding protein expression in vitro and in vivo. Int. J. Cancer 63:395401; 1995.
29. Di Saia, P. J.; Creasman, W. T. Clinical gynecologic oncology, 4th ed. St. Louis, MO: Mosby; 1993:334-335.
30. Osborn, M.; Weber, K. Tumor diagnosis by intermediate filament typing: A novel tool for surgical pathology. Lab. Invest. 48:372-393; 1983.
31. Belloni, C.; Bianchi, M. C.; Colombo, G.; Frigerio, A.; Luchini, S.; Menard, S.; Pizzetti, P.; Taccagni, G. L.; Tagliabue, E.; Colnaghi, M. I. MOv 18 monoclonal antibody in diagnostic applications: Capability to recognize the histotype of the original tumor. Tumori 76:10-13; 1990.
32. Mottolese, M.; Cianciulli, A.; Ventura, L; Perrone Donnorso, R.; Salzano, M.; Benevolo, M.; Bigotti, G.; Natali, P. G. Selected monoclonal antibodies can increase the accuracy of cytodiagnosis of neoplastic effusion of cryptic origin expanded in a short term culture. Diagnostic Cytopathol. 8:153160; 1992.
33. Mantovani, L. T.; Miotti, S.; Ménard, S.; Canevari, S.; Raspagliesi, F.; Bottini, C.; Bottero, F.; Colnaghi, M. I. Folate binding protein distribution in normal tissues and biological fluids from ovarian carcinoma patients as detected by the monoclonal antibodies MOvlg and MOvl9. Eur. J. Cancer 30:363-369; 1994.
34. Wake, N.; Hreshchyshyn, M. M.; Piver, S. M.; Matsui, S.; Sandberg, A. A. Specific cytogenetic changes in ovarian cancer involving chromosomes 6 and 14. Cancer Res. 40:45124518; 1980.
35. Perego, P.; Giarola, M.; Righetti, S. C.; Supino, R.; Caserini, C.; Delia, D.; Pierotti, M. A.; Miyashita, T.; Reed, J. C.; Zunino, F. Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems. Cancer Res. 56:556-562; 1996.
36. Bagnato, A.; Tecce, R.; Moretti, C.; Di Castro, V.; Spergel, D.; Catt, K. J. Autocrine actions of endothelin-l as a growth factor in human ovarian carcinoma cells. Clin. Cancer Res. 1: 1059-1066; 1995.
37. Yu, D.; Wolf, J. K.; Scanlon, M.; Price, J. E.; Hung, M. C. Enhanced c-erbB-2/neu expression in human ovarian cancer cells correlates with more severe malignancy that can be suppressed by E1A. Cancer Res. 53:891-898; 1993.
38. Hynes, R. O. Integrins, a family of cell surface receptors. Cell 48:549-554; 1987.
39. Sainsbury, J. R. C.; Farndon, J. R.; Needham, G. K.; Malcolm, A. J.; Harris, A. L. EGF-R status as a predictor of early recurrence of and death from breast cancer. Lancet II: 1398-1402; 1987.
40. Owens, O. J.; Leake, R. E. Epidermal-growth-factor-receptor expression in malignant ovary, benign ovarian tumours and normal ovary: A comparison. Int. J. Cancer 2:321-324; 1993.
41. Scambia, G.; Benedetti, P. P.; Battaglia, F.; Ferrandna, G.; Baiocchi, G.; Greggi, S.; Vincenzo, R. D.; Mancuss, S. Significance of epidermal growth factor receptor in advanced ovarian cancer. J. Clin. Oncol. 10:529-535; 1992.
42. Gullick, W. J. Prevalence of aberrant expression of the epidermal growth factor receptor in human cancers. Br. Med. Bull. 47:87-98; 1991.
43. Zheng, J. P.; Robinson, W. R.; Ehlen, T.; Yu, M. C.; Dubeau, L. Distinction of low grade from high grade human ovarian carcinomas on the basis of losses of heterozygosity on chromosomes 3, 6, and 11 and HER-2/neu gene amplification. Cancer Res. 51:4045-4051; 1991.
44. Morali, F.; Cattabeni, M.; Tagliabue, E.; Campiglio, M.; Menard, S.; Marzola, M.; Lucchini, V.; Colombo, N.; Mangioni, C.; Redaelli, L.; D'lncalci, M. Overexpression of p185 is not related to erbB2 amplification in ovarian cancer. Ann. Oncol. 4:775-779; 1993.
45. Mandai, M.; Konoshi, I.; Koshiyama, M.; Moro, T.; Arao, S.; Tashiro, H.; Okamura, H.; Nomura, H.; Hiai, H.; Fukumoto, M. Expression of metastasis-related nm23-Hl and nm23-H2 genes in ovarian carcinomas: Correlation with clinicopathology, EGF-R, c-erbB-2, c-erbB-3 genes, and sexsteroid-receptor expression. Cancer Res. 54:1825-1830; 1994.
46. Ullrich, A.; Schlessinger, J. Signal transduction by receptors with tyrosine-kinase activity. Cell 61:203-215; 1990.
47. Grunt, T. W.; Huber, H. The family of c-erbB genes: From basic research to clinical oncology. Onkologie 17:346-357; 1994.